LANTHANUM CARBONATE | N204734 | TAKEDA PHARMACEUTICALS USA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Shire Development LLC et al v. Lupin Limited et al 4 patentsANDA 208808lanthanum carbonate | MDD | 2016-03-02 | Terminated 2017-04-17 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Shire Development Inc. (Shire) - Citizen Petition FDA-2010-P-0309 Shire Development Inc. filed this citizen petition under sections 505(j) and 505(q) requesting that the FDA require all abbreviated new drug applications and 505(b)(2) new drug applications for generic or follow-on formulations of Fosrenol (lanthanum carbonate) oral chewable tablets to include chara | 505(q) | 2010-07-08 | Partially Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.